Amiodarone, frequently coprescribed with NOACs in patients with AF, was prescribed in 30.7% of patients treated with FXa inhibitors, 24.7% of patients treated with dabigatran, and 42.5% of patients treated with warfarin (Table). This evidence concerns the gene F10 and atrial fibrillation.